Protagonist Therapeutics Total Assets 2015-2021 | PTGX

Protagonist Therapeutics total assets from 2015 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Protagonist Therapeutics Annual Total Assets
(Millions of US $)
2020 $324
2019 $155
2018 $139
2017 $164
2016 $94
2015 $15
2014 $10
Protagonist Therapeutics Quarterly Total Assets
(Millions of US $)
2021-09-30 $373
2021-06-30 $404
2021-03-31 $298
2020-12-31 $324
2020-09-30 $217
2020-06-30 $225
2020-03-31 $135
2019-12-31 $155
2019-09-30 $155
2019-06-30 $148
2019-03-31 $132
2018-12-31 $139
2018-09-30 $149
2018-06-30 $137
2018-03-31 $149
2017-12-31 $164
2017-09-30 $110
2017-06-30 $70
2017-03-31 $83
2016-12-31 $94
2016-09-30 $103
2016-06-30 $25
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2014-12-31 $10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.375B $0.029B
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.639B 8.76
Bio-Rad Laboratories (BIO.B) United States $16.992B 34.48
QIAGEN (QGEN) Netherlands $10.895B 18.45
Biohaven Pharmaceutical Holding (BHVN) United States $7.620B 0.00
Emergent Biosolutions (EBS) United States $2.497B 8.98
Arcus Biosciences (RCUS) United States $2.167B 0.00
Myovant Sciences (MYOV) United Kingdom $1.222B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.110B 0.00
Zymeworks (ZYME) Canada $0.466B 0.00
SQZ Biotechnologies (SQZ) United States $0.206B 0.00
Ambrx Biopharma (AMAM) United States $0.195B 0.00
Enzo Biochem (ENZ) United States $0.157B 20.19